Alseres Pharmaceuticals Inc

US
ALSE
Stock
Yield per half year: 0%
Dividend yield: 0%

Reporting Alseres Pharmaceuticals Inc

Capitalization

IFRS
Reporting Annual Quarterly
1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 5 year average CAGR 5
Капитализация, млрд $
0 0.0000 0.0000 0.0000 0 0 0 0 0 0
Выручка, млрд $
0.0006 0.0004 0.0004 0.0002 0.0001 0.0001 0.0002 0 0.000531 0.000474 0.0003 36.51
Чистая прибыль, млрд $
-0.0113 -0.0115 -0.0264 -0.0195 -0.0208 -0.0108 0.000512 -0.0029 -0.0016 -0.000942 -0.0031 -38.61
EV, млрд $
0.0334 0.0352 0.0082 0.0256 -37.38
EBIT, млрд $
-0.0104 -0.0116 -0.0266 -0.0189 -0.0188 -0.0084 -0.0094 -0.0021 -0.0012 -0.000946 -0.0044 -35.39
EBITDA, млрд $
-0.0102 -0.0114 -0.0264 -0.0188 -0.0187 -0.0083 -0.0093 -0.002 -0.0012 -0.000945 -0.0043 -35.25
Баланс стоимость, млрд $
0.000569 0.0079 -0.0166 -0.0224 -0.04 -0.0475 -0.0473 -0.0306 -0.0267 -0.0107 -0.0326 -25.78
FCF, млрд $
-0.0097 -0.0107 -0.0159 -0.0245 -0.0151 -0.0081 -0.003 -0.0025 -0.000952 -0.0017 -0.0033 -26.82
Операционный денежный поток, млрд $
-0.0097 -0.0106 -0.0158 -0.0245 -0.015 -0.0081 -0.003 -0.0025 -0.000952 -0.0017 -0.0033 -26.82
Операционная прибыль, млрд $
-0.0104 -0.0116 -0.0264 -0.0189 -0.0187 -0.0083 -0.0031 -0.0016 -0.0012 -0.000565 -0.0030 -41.58
Операционные расходы, млрд $
0.0104 0.0116 0.0264 0.0189 0.0187 0.0083 0.0031 0.0016 0.0017 0.0014 0.0032 -29.95
CAPEX, млрд $
0.000541 0.000432 0.0000 0.0000 0.0001 0.0000 0.0000 0.000143 0 0 0.0003 -28.30


Balance sheet

IFRS
Reporting Annual Quarterly
1985 1986 1987 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 2000 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 5 year average CAGR 5
Наличность, млрд $
0.000153 0.000579 0.0015 0.0029 0.0001 0.000315 0.0001 0.000136 0.0000 0.000114 0.0002 2.66
Short Term Investments $
0.0049 0.0015 0.0088 0.0012 0.0001 0.0000 0.0001 0.0000 0.000881 0.000207 0.0005 -29.63
Total Receivables $
0.0006 0.0013 0.0016 0.0004 0.0004 0.0003 0.0115 0.0028 48.36
Total Current Assets $
0.0018 0.0098 0.0019 0.0052 0.000317 0.000388 0.000209 0.000168 0.0009 0.000325 0.0004 -3.48
Чистые активы, млрд $
0.000605 0.0004 0.000276 0.000136 0.0001 0.000179 0.000106 0.0000 0 0 0.0002 -17.42
Активы, млрд $
0.0025 0.0105 0.0024 0.0056 0.000845 0.000791 0.000461 0.000171 0.000966 0.000385 0.0006 -13.41
Short Term Debt $
0.0001 0.0015 0.0001 0.008 0.0000 0.0014 0.0337 0.0277 0.0064 0.000506 0.0139 -18.42
Long Term Debt $
0.0039 0.0038 0.0233 0.0335 0.0342 0.0078 0.0205 15.47
Задолженность, млрд $
0.002 0.0026 0.0189 0.028 0.0409 0.0483 0.0477 0.0308 0.0277 0.011 0.0331 -25.61
Чистый долг, млрд $
-0.000153 -0.000304 0.0065 0.0204 0.0336 0.0353 0.0337 0.0276 0.0064 0.0077 0.0221 -26.25
Долг, млрд $
0.0335 0.0356 0.0083 0.0258 -37.19
Расходы на обслуживание долга $
0.001 0.0000 0.0001 0.000876 0.0022 0.0025 0.0026 0.0018 0.000435 0.000455 0.0016 -28.88
Амортизация, млрд $
0.000218 0.000213 0.00018 0.0001 0.0001 0.0001 0.0001 0.0000 0 0 0.0001 -11.09
Себестоимость, млрд $
0.0014 0.0038 0.0003 0.0007 0.0003 0.0001 0.0001 0.0000 0.0000 0.0000 0.0003 -19.73
Товарно материальные запасы $
0.0004 0.0004 0.0004 0.00


Share

IFRS
Reporting Annual Quarterly
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
EPS -75469.84 -5433.75 -7882.34 -8903.73 -2910.01 -66.17 -504.74 -268.56 -299.26 -809.7480 -36.55
Цена акции ао 60.83 47.69 31.23 14.23 7.48 5.61 0.01 0.01 0.01 0.01 2.62 -73.38
Число акций ао, млн 0.0033 0.0033 0.0041 0.0042 0.0049 0.0064 0.0063 0.0061 0.0061 0.0061 0.0062 -0.96
FCF/акцию -6914.44 -3239.07 -4812.79 -5980.9 -3601.51 -1644.96 -461.04 -394.79 -156.14 -276.55 -586.6960 -30.00


Efficiency

IFRS
Reporting Annual Quarterly
1993 1994 1995 1996 1997 1998 1999 2000 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % -1977.52 -145.75 159.04 87.21 52.1 22.68 -1.08 9.42 6.16 8.83 9.20 -17.19
ROA, % -442.13 -109.38 -1112.56 -347.61 -2466.43 -1362.76 111.25 -1688.18 -170.39 -244.25 -670.8660 -29.09
ROS, % -3000 -8000 -6900 -7000 -532713200 -310.05 -198.75 0 0 0 -106545521.7600 -50.81
ROCE, % 160.54 84.24 46.96 17.68 19.88 6.82 4.44 8.88 0 0 11.54 -12.87
Ebit margin, % 0 0
Рентаб EBITDA, % 2125 -1950 -10100 -8300 -5500 -571427350 -223.09 -199.45 0 0 -114288314.5080 -52.56
Чистая рентаб, % -4183.33 -2075 -3525 -3000 -8000 -6900 -7000 -532713200 -310.05 -198.75 -106545521.7600 -50.81
Operation Margin, % -2450 -9100 -7600 -6350 -572672800 -228.4 -119.21 0 0 0 -114537419.5220 -56.44
Доходность FCF, % -754907.27 -160703.03 -155584.97 -218617.43 -153502.58 -216237.25 -195375.31 -364329.51 -98115.05 -442485.11 -263308.4460 15.40


Coefficients

IFRS
Reporting Annual Quarterly
1993 1994 1995 1996 1997 1998 1999 2000 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
-0.000114 -0.000578 -0.000387 -0.000574 -0.000473 -0.000346 0.0029 -0.000237 -0.00059 -0.000405 0.0003 3.20
P/BV
0.0023 0.000843 -0.000616 -0.0005 -0.000246 -7.8E-5 -3.2E-5 -2.2E-5 -3.6E-5 -3.6E-5 -0.0000 -14.33
P/S
0.000769 0.000208 0.000403 0.0019 0.0145 0.0169 0.0316 3031.25 0.0018 0.000805 606.26 -45.60
P/FCF
-0.000457 -0.000651 -0.000462 -0.000512 -0.000274 -0.001 -0.000226 0 0 0 -0.0005 -13.33
E/P
-1742.79 -2115.6 -2891.18 339.29 -4221.96 -1695.06 -2469.65 0 0 0 -2187.7120 -3.10
EV/EBIT
0 0 0
EV/EBITDA
-1.78 -4.23 -8.69 -4.9000 69.64
EV/S
17.33 0 0 0 17.33 0.00
EV/FCF
-2.21 -4.37 -4.87 0 0 0 -3.8167 30.13
Debt/EBITDA
-1.79 -4.27 -8.81 0 0 0 -4.9567 70.10
Netdebt/Ebitda
-1.09 -1.79 -4.24 -3.6 -13.49 -5.4 -8.16 0 0 0 -6.9780 13.99
Debt/Ratio
39.63 44.96 21.6 0 0 0 35.40 -18.31
Debt/Equity
-0.8373 -0.7484 -0.781 0 0 0 -0.7889 -2.29
Debt/Net Income
-1.61 -3.3 -8.84 0 0 0 -4.5833 76.42
PEG
0 0
Бета
0 0 0
Индекс Альтмана
-2.6 -5.88 0 0 0 -4.2400 50.38


Dividends

IFRS
Reporting Annual Quarterly
2004 2005 Industry average 5 year average CAGR 5
Див.выплата, млрд
0.000202 0.000315 0.0003 24.88
Дивиденды / прибыль, %
-1.79 -2.74 -2.2650 23.72


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe